NetworkNewsBreaks – Lexaria Bioscience Corp. (CS
Post# of 721
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced its entry into definitive agreements with certain qualified investors for the sale of 8,978,260 shares (“Shares”) of its common stock along with common stock purchase warrants (“Warrants”) to purchase up to 8,978,260 shares of its common stock in a private placement (collectively the “Offering”) for gross proceeds of over US$2 million. According to the update, the purchase price per Share is US$0.23. The Warrants being issued in connection with the purchase of the Shares are immediately exercisable at an exercise term of five years and price per share of US$0.35. Subject to customary conditions, the transaction is anticipated to close on May 6, 2020.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer